Skip to search formSkip to main contentSkip to account menu

T 1095

Known as: 3-(Benzo(b)furan-5-yl)-2', 6'-dihydroxy-4'-methylpropiophenone-2'-O-(6-O-methoxycarbonyl)-beta-D- glucopyranoside, T-1095 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
of JP2004359630. International Search Report for corresponding international applica tion PCT/EP2005/002618 mailed Jun. 30, 2005… 
2006
2006
T-1095, an orally active inhibitor of Na(+)-glucose cotransporter (SGLT), excretes excess plasma glucose into urine, lowers blood… 
Review
2004
Review
2004
Glucose transporters, or membrane proteins, which incorporate glucose into the cell, can be divided into two groups: the… 
2004
2004
The expression of the sodium/glucose cotransporter (SGLT), a membrane protein, is limited to renal tubules and the intestinal… 
2002
2002
1. To investigate the pharmacological effects of T‐1095, this novel derivative of phlorizin was administered to GK rats for 8… 
2002
2002
  • 2002
  • Corpus ID: 195162290
Highly Cited
2000
Highly Cited
2000
To determine the contribution of hyperglycemia to the insulin resistance in various insulin-sensitive tissues of Zucker diabetic…